United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 122

Treatment Cannabinoids Blood Pressure THC 122

Veriheal

FEBRUARY 14, 2024

The vote passed 7-0 after a group of senators, first responders, and military members held a press conference regarding the benefits and potential of psilocybin, also known as magic mushrooms , for mental health treatment. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Kathryn Tucker.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

OCTOBER 13, 2023

Along with their medical properties, psychedelics’ low potential for abuse and psychological harm means legalization is just “good public policy” Sen. Ketamine Therapy For All? Enthea Thinks So Psychedelic therapy insurance provider Enthea is looking to bring ketamine-assisted therapy to the entire U.S. Irwin says.

Therapy 98

Therapy Legalization Recreational Policy 98

Cannabis Law Report

JUNE 14, 2022

Those values guide our joint efforts to change perceptions about psychedelic assisted therapies, raise awareness of the scientific advances and, ultimately, bring better health to European citizens. Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD.

Access 52

Access Therapy Clinical Trials Treatment 52

Veriheal

MARCH 20, 2023

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

FEBRUARY 9, 2022

Food and Drug Administration designated psilocybin as a breakthrough treatment for drug-resistant depression in 2018 and for major depressive disorder in 2019. It’s an important discussion,” Meyer said of the treatment option. This is a breakthrough therapy and it shows promise, but the science is not there yet.”.

Therapy 52

Therapy Treatment Decriminalization Patients 52

MMJ Recs

MAY 1, 2024

Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.

Marijuana 98

Marijuana Treatment Conditions Chronic Pain 98

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law 59

Law Policy Research and Development Clinical Trials 59

Veriheal

FEBRUARY 23, 2024

As such, we hope that in treating the wounds of war — both visible and invisible — that our servicemembers and veterans would have access to the widest array of possible treatments,” writes an excerpt from the veterans’ letter, via NBC News. Armed Forces often face difficult physical and mental challenges upon returning home.

DEA 99

DEA Chronic Pain Treatment Therapy 99

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

MMJ Recs

JANUARY 24, 2024

Michigan, a state at the forefront of progressive healthcare initiatives, has implemented its own Medical Marijuana Program for years now in order to implement alternative treatments into mainstream medical care. The state legalized medical marijuana in 2008, establishing a framework for patients to access cannabis for therapeutic purposes.

Programs 52

Programs Marijuana Access Chronic Pain 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Legalization and Regulation of Medical Marijuana The journey of legalizing and regulating medical marijuana in the US reflects a nuanced interplay of federal and state policies.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Cannabis Law Report

JULY 29, 2021

These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. Each clinic employs a highly educated and specialized team of dedicated physicians, nurses and therapists working in unison with patients to ensure treatment goals are achieved.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

Cannabis Law Report

JUNE 5, 2021

Among other questions, the poll asked: To what extent would you support or oppose the government relaxing restrictions on research into the medical use of magic mushroom-based treatments (psilocybin- assisted therapies) for mental health conditions if this didn’t affect how it was classified in criminal law (e.g. as a class A drug)?

Therapy 81

Therapy Policy Education Treatment 81

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

SEPTEMBER 10, 2021

This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. We look forward to working closely with the Clerkenwell Health team to advance our psychedelic drug programs through clinical trials.”.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

PrestoDoctor

JANUARY 30, 2024

By exploring the signs and symptoms, risk factors, mechanism of action, and treatment options for cannabis-induced psychosis, we can better equip ourselves with the knowledge needed to prevent and manage this condition. In terms of treatment, a combination of medication and psychological interventions is common.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Veriheal

OCTOBER 19, 2022

Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. ” Desperate to find a way of relieving her daughter’s suffering, Warastuti proceeded to explore alternative treatment options, one of which was medical marijuana.

Legalization 104

Legalization Research and Development Chronic Pain Treatment 104

Cannabis Law Report

JUNE 19, 2022

The Psychedelic Access and Research European Alliance (PAREA) is a group founded in 2022 and comprised of 15 organizations with common goals in the field of mental health and psychedelics. We are equally excited about the inaugural launch of the Psychedelic Access and Research European Alliance! Opening keynote address : Prof.

Therapy 52

Therapy Advocacy Events Treatment 52

MMJ Recs

DECEMBER 26, 2022

Small lifestyle changes and simple exercises can often help; in addition, MMJ treatment can be highly effective for treating chronic pain (read more on how to apply for your NJ MMJ card below). Oftentimes, it’s far better to speak to an expert in handling chronic pain to ensure that you get the best treatment for your symptoms.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. Psychedelic Alpha Policy Map. Where Laws Are Changing.

Law 74

Law Research and Development Therapy Treatment 74

The Cannigma

JUNE 2, 2023

The possession, use, and trafficking of cannabis are illegal, and the country maintains a zero-tolerance policy towards drugs. The use of cannabis for medicinal purposes is not permitted, and there are no legal avenues for patients to access cannabis-based medications.

Law 52

Law Research and Development Consumption Therapy 52

Veriheal

AUGUST 11, 2023

In a significant move towards drug policy reform, Colorado Governor Jared Polis asked lawmakers for permission to grant pardons for individuals with certain psychedelic drug-related convictions. ” In addition, he stated that he looks forward to a time when people will no longer have to go to Columbia or Mexico for psychedelics therapy.

Decriminalization 79

Decriminalization Treatment Therapy Policy 79

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JUNE 24, 2022

Scutari’s proposed “Psilocybin Behavioral Health Access and Services Act” represents a bold development in the psychedelics reform movement that’s rapidly spread in state legislatures and through citizen-led initiatives throughout the country in recent years. Full story at.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

MAY 18, 2022

With few solutions in sight, there is a growing body of evidence that suggests that psychedelic-assisted therapy could provide a breakthrough in treating countless mental health ailments, such as depression, substance abuse disorders, and PTSD. The clinical evidence for psychedelic assisted therapy is accumulating.

Research and Development 52

Research and Development Therapy Treatment Policy 52

Cannabis Law Report

SEPTEMBER 28, 2021

The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. However, existing ACT legislation would need to be amended to allow this to proceed in the ACT,” said Ms Ollson. Here’s the details on the research project.

Therapy 52

Therapy Medicine Data Collective 52

MMJ Recs

JANUARY 20, 2024

Maryland, a trailblazer in progressive healthcare policies, has been part of this trend. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! These dispensaries, regulated by the Maryland Cannabis Administration, serve as the primary outlets for medical cannabis products.

Law 52

Law Marijuana Patients Chronic Pain 52